Glycoconjugate vaccines to prevent group B streptococcal infections

By Paoletti Lawrence C   Kasper Dennis L  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 6, 2003-09 ,pp. : 975-984

Informa Healthcare

Access to resources Recommend Favorite

Peptide-based vaccines for cancer immunotherapy

By Brinkman Joeli A   Fausch Steven C   Weber Jeffrey S   Kast W Martin  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 181-198

Informa Healthcare

Access to resources Recommend Favorite

Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines

By Mocellin S.   Rossi C.R.   Nitti D.   Lise M.   Marincola F.M.  

Biochimica et Biophysica Acta (BBA)/Reviews on Cancer, Vol. 1653, Iss. 2, 2003-12 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite

Structure and Binding Determinants of the Recombinant Kringle-2 Domain of Human Plasminogen to an Internal Peptide From a Group A Streptococcal Surface Protein

By Rios-Steiner J.L.   Schenone M.   Mochalkin I.   Tulinsky A.   Castellino F.J.  

Journal of Molecular Biology, Vol. 308, Iss. 4, 2001-05 ,pp. : 705-719

Academic Press

Access to resources Recommend Favorite

Synthetic peptide vaccines

By Moisa A.   Kolesanova E.  

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, Vol. 4, Iss. 4, 2010-12 ,pp. : 321-332

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite